Inhibitory effects of genistein in combination with gefitinib on the hepatocellular carcinoma Hep3B cell line.

In conclusion, findings from the present study suggest that genistein in combination with gefitinib inhibit HCC cell proliferation and promote apoptosis by inhibiting the Akt/Erk/mTOR pathway. PMID: 31611933 [PubMed]
Source: Experimental and Therapeutic Medicine - Category: General Medicine Tags: Exp Ther Med Source Type: research